Bank of New York Mellon Corp Has $2.24 Million Holdings in Sientra Inc (SIEN)

Share on StockTwits

Bank of New York Mellon Corp lowered its position in shares of Sientra Inc (NASDAQ:SIEN) by 20.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 176,518 shares of the medical instruments supplier’s stock after selling 44,575 shares during the period. Bank of New York Mellon Corp owned about 0.62% of Sientra worth $2,243,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in SIEN. Point72 Asset Management L.P. purchased a new stake in Sientra during the 3rd quarter valued at $3,767,000. BlackRock Inc. boosted its position in Sientra by 5.5% during the 3rd quarter. BlackRock Inc. now owns 1,572,899 shares of the medical instruments supplier’s stock valued at $37,561,000 after buying an additional 82,312 shares during the period. Federated Investors Inc. PA boosted its position in Sientra by 19,162.9% during the 3rd quarter. Federated Investors Inc. PA now owns 66,457 shares of the medical instruments supplier’s stock valued at $1,587,000 after buying an additional 66,112 shares during the period. Stephens Inc. AR boosted its position in Sientra by 133.7% during the 4th quarter. Stephens Inc. AR now owns 55,150 shares of the medical instruments supplier’s stock valued at $701,000 after buying an additional 31,550 shares during the period. Finally, Vanguard Group Inc boosted its position in Sientra by 1.4% during the 3rd quarter. Vanguard Group Inc now owns 1,017,312 shares of the medical instruments supplier’s stock valued at $24,293,000 after buying an additional 14,422 shares during the period. 90.81% of the stock is owned by institutional investors and hedge funds.

NASDAQ:SIEN opened at $7.52 on Monday. Sientra Inc has a 12 month low of $7.10 and a 12 month high of $26.79. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.12 and a quick ratio of 1.75. The stock has a market capitalization of $219.67 million, a PE ratio of -2.31 and a beta of -0.08.

Sientra (NASDAQ:SIEN) last posted its earnings results on Tuesday, March 12th. The medical instruments supplier reported ($0.86) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.67) by ($0.19). Sientra had a negative return on equity of 123.51% and a negative net margin of 121.28%. The company had revenue of $19.02 million during the quarter, compared to analysts’ expectations of $18.87 million. As a group, research analysts forecast that Sientra Inc will post -2.84 earnings per share for the current year.

Several equities research analysts have weighed in on SIEN shares. Leerink Swann dropped their price target on shares of Sientra from $22.00 to $18.00 in a research report on Wednesday, March 13th. BidaskClub raised shares of Sientra from a “strong sell” rating to a “sell” rating in a research report on Friday, March 1st. Craig Hallum set a $23.00 price target on shares of Sientra and gave the company a “buy” rating in a research report on Tuesday, March 26th. Dougherty & Co dropped their target price on shares of Sientra from $29.00 to $27.00 and set a “buy” rating for the company in a research report on Wednesday, March 13th. Finally, William Blair cut shares of Sientra from an “outperform” rating to a “market perform” rating in a research report on Wednesday, March 13th. One research analyst has rated the stock with a sell rating, four have given a hold rating and seven have given a buy rating to the company’s stock. Sientra has an average rating of “Buy” and a consensus price target of $20.44.

TRADEMARK VIOLATION NOTICE: “Bank of New York Mellon Corp Has $2.24 Million Holdings in Sientra Inc (SIEN)” was originally published by Zolmax and is the property of of Zolmax. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://zolmax.com/investing/bank-of-new-york-mellon-corp-has-2-24-million-holdings-in-sientra-inc-sien/3053725.html.

Sientra Profile

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Featured Article: Back-End Load

Want to see what other hedge funds are holding SIEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sientra Inc (NASDAQ:SIEN).

Institutional Ownership by Quarter for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Credo  Price Tops $0.0130 on Exchanges
Credo Price Tops $0.0130 on Exchanges
MARK.SPACE  Market Capitalization Achieves $4.55 Million
MARK.SPACE Market Capitalization Achieves $4.55 Million
Numeraire Trading Up 32.8% This Week
Numeraire Trading Up 32.8% This Week
BitDegree  Reaches One Day Volume of $619.00
BitDegree Reaches One Day Volume of $619.00
Online  Trading Up 32.5% Over Last 7 Days
Online Trading Up 32.5% Over Last 7 Days
HOQU Reaches Market Cap of $1.22 Million
HOQU Reaches Market Cap of $1.22 Million


 
© 2006-2019 Zolmax.